Innoviva, Inc.
NASDAQInnoviva, Inc. heads into its Q1 2026 print tonight with options positioning nudging more defensive against a stock that has drifted quietly lower. The most notable pre-earnings signal is in options. Put/call activity has picked up relative to recent norms: the PCR climbed to 0.10, roughly 1.3 standard deviations above its 20-day average of 0.07. That is still a low absolute…
Snapshot as of 22 Jun 2026
Innoviva, Inc. heads into its Q1 2026 print tonight with options positioning nudging more defensive against a stock that has drifted quietly lower. The most notable pre-earnings signal is in options. Put/call activity…
Innoviva reported Q1 2026 results after the close on May 6, posting a massive EPS beat — $2.22 actual against a $0.36 consensus estimate — while revenue of $97.99 million came in slightly short of the $101.56 million…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for INVA — free to start on ORTEX.
Sign up for free →Open INVA on ORTEX